Indexed metadata
Proof of efficacy for Seladelpar, a selective PPAR-δ agonist, in patients with primary biliary cholangitis non-responsive to ursodeoxycholic acid: results of an international Phase 2 randomised controlled clinical study
G.M. Hirschfield, M.R. Galambos, C.L. Bowlus, M.G. Swain, Y. Doerffel, A.S. Steinberg, M. Varga, Y.-J. Choi, R.L. Martin, H. Chera, C.A. McWherter, P.F. Boudes, D. Jones
Source record
Source: Crossref
Published: Jan 1, 2017
DOI: 10.1016/s0168-8278(17)31052-8
Open original source ↗Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.